Human Heart Transplantation: Current Status
|
|
- Anabel Farmer
- 6 years ago
- Views:
Transcription
1 Human Heart Transplantation: Current Status Randall B. Griepp, M.D., Edward B. Stinson, M.D.," Charles P. Bieber, M.D., Bruce A. Reitz, M.D., Jack G. Copeland, M.D., Philip E. Oyer, M.D., and Norman E. Shumway, M.D. ABSTRACT The overall survival rate for 97 heart transplant recipients operated on from 1968 to 1975 has been 49% at one year and 23% at five years. Progressive improvement in one-year survival has been achieved, from 22% in 1968 to 62% in The major factors responsible for increasing survival are better understanding and management of acute and chronic rejection. Current results suggest that heart transplantation deserves wider application in the treatment of selected patients with end-stage myocardial insufficiency. Considerable interest in cardiac transplantation has been maintained in our institution since 1968 and had resulted in the performance of 102 transplants in 97 patients by the end of The clinical experience accumulated in caring for these patients, coupled with input from studies carried out in the animal laboratory, has led to a progressive increase in patient survival and rehabilitation. Within the last few years, several important advances have been made in the treatment of acute and chronic rejection. This communication deals chiefly with the management of these two entities. Acute Rejection Maintenance Immunosuppression Azathioprine and corticosteroids remain the primary agents for maintenance immunosuppression following heart transplantation. An azathioprine loading dose of 5 mg per kilogram of body weight is given immediately preoperatively. Maintenance azathioprine is begun postoperatively as soon as the patient is able to take From the Department of Cardiovascular Surgery, Stanford University School of Medicine, Stanford, CA. *Established Investigator, American Heart Association. Presented at the Twelfth Annual Meeting of The Society of Thoracic Surgeons, Jan 26-28, 1976, Washington, DC. Address reprint requests to Dr. Griepp, Department of Cardiovascular Surgery, Stanford University Medical Center, 300 Pasteur Dr, Stanford, CA oral medications and is continued indefinitely at the highest dose compatible with adequate marrow function, usually 2 to 3 mglkg daily. Corticosteroid therapy consists of intravenous methylprednisolone, initially administered intraoperatively and then continued for 48 hours following operation. Subsequently oral prednisone is administered, beginning with 1.5 mglkg daily, then tapering to 1 mglkg by two months postoperatively and to 0.5 mglkg by six months. Thereafter, a continual effort is made to decrease prednisone to the lowest dose compatible with satisfactory allograft function. Longterm maintenance doses average 0.4 mglkg daily. Intramuscular rabbit anti-humanthymocyte globulin (RATG) is begun immediately after the operation and continued for the first ten postoperative days. Diagnosis Electrocardiographic evaluation and cardiac auscultation remain the two most important clinical surveillance techniques for detecting an acute rejection crisis [5]. Electrocardiographic correlates of rejection consist of an overall decrease in QRS voltage, the appearance of arrhythmias (usually atrial in origin), and in some instances a rightward shift of the mean QRS vector. At the time of operation an epicardial lead is attached to the donor atrium, and a decrease in the QRS voltage recorded from this lead may be the harbinger of an acute rejection crisis. The most useful physical finding in diagnosing an acute rejection crisis is the appearance of a ventricular filling sound, most frequently an S gallop. In the absence of acute rejection injury, gallop sounds are not characteristic of the human heart transplant, and the intensity of the gallop sound during an acute rejection crisis serves as a useful indicator of the severity of rejection. Endomyocardial biopsy has substantially in- 171
2 172 The Annals of Thoracic Surgery Vol 22 No 2 August 1976 creased the certainty with which the diagnosis of acute rejection can be made and also provides objective evidence of the efficacy of antirejection therapy [31. Cardiac biopsy is performed under local anesthesia by introducing a biopsy forceps into the internal jugular vein using a modified Seldinger technique. Under fluoroscopic control the biopsy forceps is guided into the right ventricle, and a 1 x 3 mm specimen of myocardium is removed from the intraventricular septum (Fig 1). Sufficient tissue can usually be obtained for staining with hematoxylin and eosin and with methylpyronine green. When it is important to determine the presence of rejection on an emergency basis, frozen sections have been helpful. To date, 470 endomyocardial biopsies have been performed in recipients of cardiac transplants. Satisfactory tissue for diagnosis has been obtained in more than 95% of these biopsies. Complications have been relatively minor and consisted of premature ventricular contractions in approximately 20%, supraventricular arrhythmias in 3%, and pneumothorax caused by trauma to the apical pleura during introduction of the biopsy forceps in 2%. Using a combination of clinical and histological findings, it has been possible to standardize the diagnosis and management of acute rejection. A drop of 20% or more in the QRS voltage Fig I. Technique of endomyocardial biopsy. (from either the standard electrocardiographic leads or the atrial wire), the development of a new arrhythmia, or the appearance of a gallop sound are considered presumptive evidence of acute rejection injury, and an endomyocardial biopsy is obtained within several hours. If the clinical findings argue strongly for the presence of acute rejection or if there is reason to believe that the presumptive episode is likely to be a severe one, antirejection therapy is begun immediately after obtaining the biopsy. If the clinical findings are equivocal, therapy is delayed for approximately twelve hours until permanent histological sections can be obtained. Antirejection therapy involves increasing the dosage of corticosteroids, and occasionally RATG, and beginning administration of actiriomycin D and heparin. The complete treatment regimen consists of the following: 1. Methylprednisolone, 1.0 gmivdaily for2 to4 days. 2. Actinomycin D, 200 pg IV daily for 1 to 3 days. 3. Antithymocyte globulin IM for 3 to 5 days. 4. Prednisone increased for 10 to 14 days. 5. Heparin IV for 5 to 7 days. Rabbit Antithymocyte Globulin (IIATG) During the first two years following the inception of clinical cardiac transplantation we used heterologous antisera producedl from horses, against either thoracic duct lymphocytes or splenocytes, as an immunosuppressive adjunct. Subsequently we found horse anti-humanthymocyte globulin (HATG) to be somewhat more efficacious than the earlier preparations [6]. In late 1973 we made a further change and began using antithymocyte globulin raised in rabbits. The procedures for immunization and harvesting of the rabbit antiserum are similar to the protocol used by Davis and colleagues [41. The purified globulin fraction is administered intramuscularly in a dose of 3 to 15 mglkg on postoperative days 1, 2,3, 5, 7,,and 9. Doses of individual batches are adjusted on the basis of the sheep red blood cell rosette inhibition titers. Serum levels of rabbit globulin in the cardiac recipients are assayed serially utilizing a modified Farr technique [ll.
3 173 Griepp et al: Human Heart Transplantation Table I. Comparison of the Efficacy of RATG and HATG in Preventing Rejection Factola RATG HATG p Value Rejection onset 23.8 f f Rejection frequency 2.9 f f Rejection score 4.7 f f 'Rejection onset is the postoperative day on which the first rejection crisis is diagnosed. Rejection frequency is the number of rejection episodes per 100 patient-days occurring in the first two postoperative months. Rejection score is computed similarly to rejection frequency except that each episode is graded mild, moderate, or severe and weighted accordingly in the calculation of score. Mean values are shown with standard errors. Factors indicative of rejection in the first 29 patients receiving RATG were compared with those in the last 20 patients receiving HATG. In all patients, episodes of acute rejection were confirmed by cardiac biopsy. As shown in Table 1, by each of the three variables assayed, rejection was significantly less severe in patients who were given RATG than in those receiving HATG. Serial determination of rabbit globulin levels allowed the patients receiving RATG to be divided into two distinct groups as determined by the kinetics of rabbit globulin elimination from the serum. In 19 patients rabbit globulin was rapidly eliminated, with a mean half life of 1.4 k 0.4 days. In 10 patients the serum rabbit globulin half-life was prolonged, with values ranging from 4 to 18 days and averaging 9.0 f 4.3 days. Table 2 compares rejection indicators in these two groups of patients. It is readily apparent that in patients in whom rabbit globulin was eliminated in a slow and presumably nonimmune fashion, the incidence and severity of acute rejection were substantially diminished. Thus it is apparent not only that RATG is a more potent immunosuppressive agent than HATG, but also Table 2. Comparison of Rejection in Patients with Rapid versus Slow RATG Clearance from the Serum Slow Rapid Factola Elimination Elimination p Value Rejection onset 32.3 k f Rejection frequency 1.9 f f Rejection score 2.5 f f "See Table 1 for explanation. that more effective immunosuppression is obtained in patients in whom RATG is not subject to immune elimination. Chronic Rejection Although survival immediately following transplantation depends upon the management of acute rejection episodes and infections, it became apparent relatively early in our experience that the major determinant of long-term survival of the cardiac allograft recipient was development of arteriosclerosis in the transplanted heart. Our first long-term survivor died at twenty-one months of an acute myocardial infarction, and extensive coronary artery lesions were evident at postmortem examination. Similar findings were present postmortem in Barnard's first long-term survivor [lo]. Based on the histological appearance of the lesions and the rapidity with which they developed, a tentative hypothesis for the pathogenesis of graft arteriosclerosis was formulated. It seems probable that the initial event is immune injury to the tunica intima of the coronary vessel, resulting in endothelial slough and exposure of a thrombogenic surface. Microthrombi, consisting predominantly of platelets, accumulate and undergo organization, forming a small intimal lesion. Repetition of this process, compounded by the infiltration of plasma lipids into the hypertrophied tunica intima, which elicits additional inflammation, results in continuous formation of intimal lesions and consequent luminal narrowing. A schema of the proposed pathogenic mechanism is shown in Figure 2. On the basis of this hypothesis and studies performed by Kincaid-Smith [9] in renal allo- Fig2. Proposed pathogenesis ofgraft arteriosclerosis. IMMUNE INJURY TO VESSEL WALL J MICROTHROMBOSIS PRoLIFERATIVE REPAIR ORGANIZATION \ / HYPERLlPlDEMlA INFILTRATION OF INTIMAL PROLIFERATION HYPERTROPHIED \?IMA GRAFT ARTERIOSCLEROSIS
4 174 The Annals of Thoracic Surgery Vol 22 No 2 August 1976 graft recipients, we thought that a combination of antithrombotic therapy and a sustained attempt to lower plasma lipid levels might be effective in reducing the severity of graft arteriosclerosis. Accordingly, after January, 1970, all patients receiving cardiac allografts were placed on a continuous regimen of warfarin and dipyridamole following transplantation and were given a diet low in cholesterol and saturated fat, with calorie restriction designed to maintain normal body weight. The incidence of graft arteriosclerosis has subsequently been assayed by annual coronary arteriography or postmortem examination [8]. Figure 3 depicts the time-related incidence of graft arteriosclerosis in all patients in our series who have survived beyond three months. Group I consists of 9 three-month survivors operated on prior to 1970 (before initiation of the regimen designed to prevent graft arteriosclerosis), and group I1 consists of 40 three-month survivors in whom the regimen was utilized. It is clear that the incidence of graft arteriosclerosis has been substantially reduced, and it no longer appears to be a significant cause of late mortality from three to five years postoperatively [71. Tissue Typing Complete histocompatibility antigen (HL-A) typing of both donor and recipient has been obtained in 89 of our 97 allograft recipients [2]. In 10 patients with 0 or 1 HL-A antigen incompatibilities the one-year survival was 24% (2 Fig3. Incidence of graft arteriosclerosis in two groups of heart transplant patients: Group 1-9 patients not on the prophylactic regimen for graft arteriosclerosis; Group 1140 patients on the prophylactic regimen (see text forfull explanation). The probability that the difference between these two populations is due to chance is less than , I POSTOP YEARS patients); in 19 patients with 2 mismatches it was 53% (10 patients); in 37 patients with 3 mismatches, 48% (18 patients); and in 23 patients with4 mismatches, 55% (13 patients). No significant differences in survival have occurred between any of the groups, and in addition, no correlation between the number of HL-A mismatches and history of rejection has been evident. In the last two years one of us has devised a technique for calculating match score in which specific HL-A incompatibilities are weighted by the frequency with which antibo'dies are formed during pregnancy in the face of known maternal-offspring HL-A incompatibilities. Utilizing this statistic, a significant correlation emerges between match score and survival [71. At present, however, this correlation does not appear strong enough to justify using match score to determine suitable cardiac donors preoperatively. Retransplantation Cardiac retransplantation has been carried out 5 times in our series. In 1 patient successful retransplantation was accomplished 24 hours following placement of the initial graft, which had an extremely unstable rhythm with resultant compromise of hemodynamic function. In 2 patients retransplantation was carried out during the first two postoperative months because of unremitting, drug-resistant, acute rejection injury. In 1 of these patients the second graft was rejected within two weeks, but acute rejection in the other patient was relatively easy to control, and the patient is at present a long-term survivor. Cardiac retransplantation was required in 2 patients because of the develo.pment of severe coronary artery lesions in the original graft after two to five years. One of them died postoperatively of a fungal infection that had been present at the time of retransplantation. The second patient continued to do well more than one year following placement of his seccind graft. Survival and Rehabilitation Figure 4 depicts the survival curve of the 97 patients who have received heart transplants. The majority of deaths occurred within the first year following transplantation, so that if an individual reaches his first anniversary, he has approximately a 50% chance of continuing to
5 175 Griepp et al: Human Heart Transplantation 1.20 I \,+NOT TRANSPLANTED I34 PTS) POSTOP YEARS -.- Fig4. Survival of 97 patients who received heart transplants and34 patients selected for transplantation who died before a donor became available E Y z YEAR Fig5.One-year survival by calendar year in the Stanford University series. survive for five years following operation. Also shown in Figure 4 is the survival curve for 34 patients who were selected for transplantation but who died before a suitable donor became available; all had died by one year following selection. Figure 5 depicts one-year survival by calendar year from 1968 through 1974, the last year in which a complete one-year survival can be ascertained. Progressive improvement in one-year survival is apparent; 1974 one-year survival was 62%. The statistics for rehabilitation, which is as important as survival, are equally encouraging. Of the 37 patients in our series who have survived for one year or more, 32 (86%) have been rehabilitated to New York Heart Association Functional Class I. References 1. Bieber CP, Lydick E, Griepp RB, et al: Radioimmune assay of heterologous serum gamma globulin in patients receiving rabbit antihuman thymocyte globulin. Transplantation 20:393,1975 I Bodmer W, Tripp M, Bodmer J: Application of a fluorochromatic cytotoxicity assay to human leukocyte typing, Histocompatibility Testing. Edited by ES Curtoni, PL Mattiuz, RM Tosi. Copenhagen: Munksgaard, 1967, p 341 Caves PK, Stinson EB, Billingham ME, et al: The diagnosis of human cardiac allograft rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg 66:461, 1973 Davis RC, Glasgow AH, Williams LF Jr, et al: Trial of rabbit antihuman ALG in cadaver kidney transplantation. Transplant Proc 3:766, 1971 Griepp RB, Stinson EB, Dong E Jr, et al: Acute rejection of the allografted human heart. Ann Thorac Surg 12:113, 1971 Griepp RB, Stinson EB, Dong E Jr, et al: The use of antithymocyte globulin in human heart transplantation. Circulation 45:Suppl 2:147, 1972 Griepp RB, Stinson EB, Oyer PE, et al: Management of long-term survivors of heart transplantation. Transplant Proc 7:Suppl 1:595, 1975 Griepp RB, Wexler L, Stinson EB, et al: Coronary arteriography following cardiac transplantation. JAMA 221:147, 1972 Kincaid-Smith P: Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants. Lancet 2:920, 1969 Thomson JG: Production of severe atheroma in a transplanted human heart. Lancet 2:1088, 1969 Discussion DR. GRIEPP: It is always a pleasure to present these data, but sometimes I wonder whether a paper on heart transplantation is accepted on its merits or because it saves time during the discussion period. I should like to present some additional information as an encouragement to others contemplating initiation of a program in heart transplantation. We have plotted the cost of heart transplantation over the years compared with the cost of aortic valve replacement in our hospital. In 1970 the average cost of heart transplantation was about $20,000, approximately six times the cost of an aortic valve replacement. In the past year the average cost of a heart transplant was just under $30,000, but this now represents only four times the cost of aortic valve replacement. Thus, the cost of heart transplantation is decreasing in comparison to more standard types of cardiac operations. With respect to long-term survival and rehabilitation, 5 patients have currently lived beyond five years. Our longest survivor is a man who is alive and active more than six years following operation. Most of our long-term survivors are doing quite well and leading close to normal lives. More than 85% of the one-year survivors are in New York Heart Association Functional Class I, and of these patients, greater than 80% have returned to gainful employment.
Acute Rejection in the Long-Term Cardiac Transplant Survivor
Acute Rejection in the Long-Term Cardiac Transplant Survivor Clinical Diagnosis, Treatment and Significance By ANTHONY F. GRAHAM, M.D., F.R.C.P., ALAN K. RIDER, M.D., PHILIP K. CAVES, M.B., F.R.C.S., EDWARD
More informationAcute Rejection of the Allografted Human Heart
THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 12 * NUMBER 2 AUGUST 1971 Acute Rejection of the Allografted Human Heart
More informationDevelopment of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone
THERAPY AND PREVENTION CARDIAC TRANSPIANTATION Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone BARRY F. URETSKY,
More informationPost Operative Management in Heart Transplant นพ พ ชร อ องจร ต ศ ลยศาสตร ห วใจและทรวงอก จ ฬาลงกรณ
Post Operative Management in Heart Transplant นพ พ ชร อ องจร ต ศ ลยศาสตร ห วใจและทรวงอก จ ฬาลงกรณ Art of Good Cooking Good Ingredient Good donor + OK recipient Good technique Good team Good timing Good
More information- Transplantation: removing an organ from donor and gives it to a recipient. - Graft: transplanted organ.
Immunology Lecture num. (21) Transplantation - Transplantation: removing an organ from donor and gives it to a recipient. - Graft: transplanted organ. Types of Graft (4 types): Auto Graft - From a person
More informationS plantation has become an accepted therapy for endstage
HLA Histocompatibility Affects Cardiac Transplant Rejection and May Provide One Basis for Organ Allocation Verdi J. DiSesa, MD, Paul C. Kuo, MD, Keith A. Horvath, MD, Gilbert H. Mudge, MD, John J. Collins,
More information158 Ann Thorac Surg 45: , Feb Copyright by The Society of Thoracic Surgeons
Value of Urinary Polyamines as Noninvasive Markers of Cardiac Allograft Rejection in the Dog Michel Carrier, M.D., Diane H. Russell, Ph.D., Thomas P. Davis, Ph.D., Robert W. Emery, M.D., and Jack G. Copeland,
More informationSINCE the introduction of Imuran and
Cadaveric Renal Transplantation With Cyclosporin-A and Steroids T. R. Hakala, T. E. Starzl, J. T. Rosenthal, B. Shaw, and S. watsuki SNCE the introduction of muran and prednisone in 1961, and despite the
More informationThe diagnosis and treatment of cardiac rejection is
ORIGINAL ARTICLES: CARDIOVASCULAR Routine Surveillance Endomyocardial Biopsy: Late Rejection After Heart Transplantation David A. Heimansohn, MD, Robert J. Robison, MD, John M. Paris III, MD, Robert G.
More informationTwenty-Year Survivors of Heart Transplantation at Stanford University
American Journal of Transplantation 2008; 8: 1769 1774 Wiley Periodicals Inc. Special Article C 2008 The Authors Journal compilation C 2008 The American Society of Transplantation and the American Society
More informationAcute Isolated Pulmonaw Reiection Following Transplantatich of the Heart and Both Lungs: Experimental and Clinical Observations
Acute Isolated Pulmonaw Reiection Following Transplantatich of the Heart and Both Lungs: Experimental and Clinical Observations D. Novitzky, M.D., D. K. C. Cooper, Ph.D., F.R.C.S., A. G. Rose, Ch.B., M.Med.(Path),
More information1980s-1990s1990s 9/24/2010. David Wojciechowski and. Mary Kennedy-Breiner. Laurie Carlson. Janine Sabatte- Caspillo
Factors Influencing Length of Stay: 1980s-1990s1990s Mail the Get Well Cards Home!! Effectively Managing Shorter Length of Stays David Wojciechowski and Higher rejection rates Longer duration of induction
More informationHLA Compatibility and Cardiac Transplant Recipient Survival
HLA Compatibility and Cardiac Transplant Recipient Survival William H. Frist, M.D., Philip E. Oyer, M.D., Ph.D., John C. Baldwin, M.D., Edward B. Stinson, M.D., and Norman E. Shumway, M.D., Ph.D. ABSTRACT
More informationAtgam (lymphocyte immune globulin, anti-thymocyte globulin [equine])
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.20.01 Subject: Atgam Page: 1 of 5 Last Review Date: June 24, 2016 Atgam Description Atgam (lymphocyte
More informationMODERATOR Felix Rapaport, other members of this
The First Lung Transplant in Man (1963) and the First Heart Transplant in Man (1964) J.D. Hardy MODERATOR Felix Rapaport, other members of this distinguished panel, and members of the audience, I will
More informationin Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D.
Factors Relating to Late Sudden Death in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D. ABSTRACT The preoperative
More informationUniversity of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives
University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Lefaucheur C, Loupy A, Vernerey D, et al. Antibody-mediated
More informationFigure 2. Normal ECG tracing. Table 1.
Figure 2. Normal ECG tracing that navigates through the left ventricle. Following these bundle branches the impulse finally passes to the terminal points called Purkinje fibers. These Purkinje fibers are
More informationLong-term efficacy and safety of conversion to tacrolimus in heart. transplant recipients with ongoing or recurrent acute cellular.
Long-term efficacy and safety of conversion to tacrolimus in heart transplant recipients with ongoing or recurrent acute cellular rejection Blanka Skalická, Ivan Málek, Miloš Kubánek, Jevgenija Vymětalová,
More informationCirculatory System. Functions and Components of the Circulatory System. Chapter 13 Outline. Chapter 13
Circulatory System Chapter 13 Chapter 13 Outline Functions and Components of the Circulatory System Composition of Blood Structure of the Heart Cardiac Cycle and Heart Sounds Electrical Activity of the
More informationImmunosuppressants. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Immunosuppressants Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Immunosuppressive Agents Very useful in minimizing the occurrence of exaggerated or inappropriate
More informationHeart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017
Heart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017 Randall C Starling MD MPH FACC FAHA FESC FHFSA Professor of Medicine Kaufman Center for Heart Failure Department of Cardiovascular
More informationPharmacology notes Interleukin-2 receptor-blocking monoclonal antibodies: evaluation of 2 new agents
BUMC Proceedings 1999;12:110-112 Pharmacology notes Interleukin-2 receptor-blocking monoclonal antibodies: evaluation of 2 new agents CHERYLE GURK-TURNER, RPH Department of Pharmacy Services, BUMC wo mouse/human
More informationPENILE TRANSPLANTATION SURGERY
PENILE TRANSPLANTATION SURGERY First successful penile transplant was performed at Tygerberg Academic Hospital on 11 December 2014 by a team of plastic surgeons and urologists The patient was 21 years
More informationPatient Education Transplant Services. Glossary of Terms. For a kidney/pancreas transplant
Patient Education Glossary of Terms For a kidney/pancreas transplant Glossary of Terms Page 18-2 Antibody A protein substance made by the body s immune system in response to a foreign substance. Antibodies
More informationThe Circulatory System. The Heart, Blood Vessels, Blood Types
The Circulatory System The Heart, Blood Vessels, Blood Types The Closed Circulatory System Humans have a closed circulatory system, typical of all vertebrates, in which blood is confined to vessels and
More informationPatient Education. Transplant Services. Benefits and. Of a kidney/pancreas transplant
Patient Education Benefits and Risks Of a kidney/pancreas transplant This chapter discusses the benefits as well as the risks of a kidney and/or pancreas transplant. The complications of transplant and
More informationIdiopathic Hypertrophic Subaortic Stenosis and Mitral Stenosis
CASE REPORTS Idiopathic Hypertrophic Subaortic Stenosis and Mitral Stenosis Martin J. Nathan, M.D., Roman W. DeSanctis, M.D., Mortimer J. Buckley, M.D., Charles A. Sanders, M.D., and W. Gerald Austen,
More informationEffect of Acute Allograft Rejection on Exercise Hemodynamics in Patients Who
Effect of Acute Allograft Rejection on Exercise Hemodynamics in Patients Who Have Undergone Cardiac Transplantation* John N. Nanas, MD; Maria I. Anastasiou-Nana, MD; Richard B. Sutton, MD; and Theofilos
More informationEndothelitis in cardiac allograft biopsy specimens: Possible relationship to antibody-mediated rejection
http://www.jhltonline.org ORIGINAL CLINICAL SCIENCE Endothelitis in cardiac allograft biopsy specimens: Possible relationship to antibody-mediated rejection Fabio Tavora, MD, a Raghava Munivenkatappa,
More informationDiagnosis and Management of Acute Myocardial Infarction
Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that
More informationCPT Code Details
CPT Code 93572 Details Code Descriptor Intravascular Doppler velocity and/or pressure derived flow reserve measurement ( vessel or graft) during angiography pharmacologically induced stress; each additional
More informationSolid phase radioimmunoassay for /^-microglobulin; a sensitive index for renal allograft evaluation
Solid phase radioimmunoassay for /^-microglobulin; a sensitive index for renal allograft evaluation Manjula S. Kumar, Ph.D. Department of Immunopathology William E. Braun, M.D. Department of Hypertension
More informationEfficacy and Safety of Thymoglobulin and Basiliximab in Kidney Transplant Patients at High Risk for Acute Rejection and Delayed Graft Function
ArtIcle Efficacy and Safety of Thymoglobulin and Basiliximab in Kidney Transplant Patients at High Risk for Acute Rejection and Delayed Graft Function Guodong Chen, 1 Jingli Gu, 2 Jiang Qiu, 1 Changxi
More informationGlossary. Anesthesiologist A doctor who puts you or parts of your body to sleep during surgery.
1-Glossary Glossary Acute rejection A type of rejection that occurs when immune cells from your body attack the transplanted organ(s). Acute rejection may occur at any time after a transplant. But it usually
More informationCardiac Transplantation with Cyclosporin A and Prednisone
ANNALS OF SURGERY VOL. 196 (3) 324-329 1982 Cardiac Transplantation with Cyclosporin A and Prednisone BARTLEY P. GRIFFITH, M.D., ROBERT L. HARDESTY, M.D., G. MICHAEL DEEB, M.D., THOMAS E. STARZL, M.D.,
More informationCASE 10. What would the ST segment of this ECG look like? On which leads would you see this ST segment change? What does the T wave represent?
CASE 10 A 57-year-old man presents to the emergency center with complaints of chest pain with radiation to the left arm and jaw. He reports feeling anxious, diaphoretic, and short of breath. His past history
More informationInterstitial Inflammation
Interstitial Inflammation Currently considered to be T cell-mediated process Plasma cell rich acute rejection often associated with AMR Preliminary data suggests that interstitial follicular helper T cells
More information2/28/2017. Adult Heart Transplants Donor and Recipient Characteristics UNOS, Retransplant VCM. Other /2015 (N = 24,474)
1 46% 2% 3% 4% 0% 2% 2% CHD HCM ICM NICM RCM 49% 3% 3% 3% 1% 3% 3% Retransplant VCM 42% Other 35% 1/1982 6/2015 1/2009 6/2015 2016 JHLT. 2016 Oct; 35(10): 1149-1205 UNOS, 2017 Adult Heart Transplants Donor
More informationDr. Yi-chi M. Kong August 8, 2001 Benjamini. Ch. 19, Pgs Page 1 of 10 TRANSPLANTATION
Benjamini. Ch. 19, Pgs 379-399 Page 1 of 10 TRANSPLANTATION I. KINDS OF GRAFTS II. RELATIONSHIPS BETWEEN DONOR AND RECIPIENT Benjamini. Ch. 19, Pgs 379-399 Page 2 of 10 II.GRAFT REJECTION IS IMMUNOLOGIC
More information2.02 Understand the functions and disorders of the circulatory system
2.02 Understand the functions and disorders of the circulatory system 2.02 Understand the functions and disorders of the circulatory system Essential questions: What are the functions of blood? What are
More informationImmunopathology of T cell mediated rejection
Immunopathology of T cell mediated rejection Ibrahim Batal MD Columbia University College of Physicians & Surgeons New York, NY, USA Overview Pathophysiology and grading of TCMR TCMR is still a significant
More informationCertified Clinical Transplant Nurse (CCTN) * Detailed Content Outline
I. PRETRANSPLANTATION CARE 9 11 3 23 A. Evaluate End-Stage Organ Failure 1 1 1 3 1. History and physical assessment 2. Vital signs and / or hemodynamic parameters 3. Lab values 4. Diagnostic tests B. Monitor
More informationSurgical Options to Prevent and Treat Tricuspid Valve Regurgitation in Heart Transplant Recipients
Surgical Options to Prevent and Treat Tricuspid Valve Regurgitation in Heart Transplant Recipients Alejandro Bertolotti, MD Favaloro Foundation Argentina Disclosure: Conflict Of Interest Nothing to disclose
More informationBK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy
BK virus infection in renal transplant recipients: single centre experience Dr Wong Lok Yan Ivy Background BK virus nephropathy (BKVN) has emerged as an important cause of renal graft dysfunction in recent
More informationCyclosporin A in Cardiac Transplantation: Medium-term Results in 62 Patients
Cyclosporin A in Cardiac Transplantation: Medium-term Results in 62 Patients Mohsin Hakim, F.R.C.S., M.R.C.P., John Wallwork, B.Sc., F.R.C.S., and Terence English, B.Sc., F.R.C.S. ABSTRACT Between March,
More informationPathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD
Pathophysiology of Cardiovascular System Dr. Hemn Hassan Othman, PhD hemn.othman@univsul.edu.iq What is the circulatory system? The circulatory system carries blood and dissolved substances to and from
More informationStructure and organization of blood vessels
The cardiovascular system Structure of the heart The cardiac cycle Structure and organization of blood vessels What is the cardiovascular system? The heart is a double pump heart arteries arterioles veins
More informationTransplantation. Immunology Unit College of Medicine King Saud University
Transplantation Immunology Unit College of Medicine King Saud University Objectives To understand the diversity among human leukocyte antigens (HLA) or major histocompatibility complex (MHC) To know the
More informationA come the standard for surgical treatment of endstage
Cardiac Transplantation With CorticosteroidFree Immunosuppression: LongTerm Results K. Francis Lee, D, Janet D. Pierce, PhD, ichael L. Hess, D, Andrea K. Hastillo, D, Andrew S. Wechsler, D, and Albert
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationSection 5.1 The heart and heart disease
Section 5.1 The heart and heart disease Mammals are too large to rely on diffusion. They need a circulatory system to move substances around the body. Blood moves down pressure gradients, from high to
More informationCommon Codes for ICD-10
Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified
More informationLab 16. The Cardiovascular System Heart and Blood Vessels. Laboratory Objectives
Lab 16 The Cardiovascular System Heart and Blood Vessels Laboratory Objectives Describe the anatomical structures of the heart to include the pericardium, chambers, valves, and major vessels. Describe
More informationEKG Competency for Agency
EKG Competency for Agency Name: Date: Agency: 1. The upper chambers of the heart are known as the: a. Atria b. Ventricles c. Mitral Valve d. Aortic Valve 2. The lower chambers of the heart are known as
More informationb) List the steps that may occur in hemostasis with a brief explanation of what happens in those steps.
UNIT 6: CARDIOVASCULAR SYSTEM 1) List the three general functions of BLOOD. REVIEW QUESTIONS Blood 2) a) What are the three formed elements /cellular elements in blood (use anatomy vocabulary)? b) List
More informationUniversity of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives
Background: The field of critical care cardiology has evolved considerably over the past 2 decades. Contemporary critical care cardiology is increasingly focused on the management of patients with advanced
More informationTopic 6: Human Physiology
Topic 6: Human Physiology 6.2 The Blood System D.4 The Heart Essential Questions: 6.2 The blood system continuously transports substances to cells and simultaneously collects waste products. D.3 The chemical
More informationSyncope: Ockham s Razor
Syncope: Ockham s Razor Time/Place Wednesday, 25 th January 2006 10am-12pm Room 210, Wallace Wurth Building Facilitators Michael Grimm & Tony Grabs Aims Illustrate multiple possible causes for a common
More informationChapter 4 Section 24.2
Surgery Chapter 4 Section 24.2 Issue Date: December 11, 1986 Authority: 32 CFR 199.4(e)(5) 1.0 CPT 1 PROCEDURE CODES 33940-33945, 33975-33980 2.0 POLICY 2.1 Benefits are allowed for heart transplantation.
More informationRight-Sided Bacterial Endocarditis
New Concepts in the Treatment of the Uncontrollable Infection Agustin Arbulu, M.D., Ali Kafi, M.D., Norman W. Thorns, M.D., and Robert F. Wilson, M.D. ABSTRACT Our experience with 25 patients with right-sided
More informationSolid Organ Transplant
Solid Organ Transplant Lee R. Goldberg, MD, MPH, FACC Associate Professor of Medicine Medical Director, Heart Failure and CardiacTransplant Program University of Pennsylvania Disclosures Thoratec Consulting
More informationand Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D.
Combined Valvular and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. ABSTRACT Between July, 97, and March, 975,45 patients underwent combined valvular
More informationAspirin or Coumadin as the Drug of Choice
Aspirin or Coumadin as the Drug of Choice for Valve Replacement with Porcine Bioprosthesis L. Nufiez, M.D., M. Gil Aguado, M.D., D. Celemin, M.D., A. Iglesias, M.D., and J. L. Larrea, M.D. ABSTRACT Eight
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, radiofrequency, anesthetic considerations for, 479 489 Acute aortic syndrome, thoracic endovascular repair of, 457 462 aortic
More informationLONG-TERM RESULTS OF CARDIAC TRANSPLANTATION IN PATIENTS OLDER THAN SIXTY YEARS
LONG-TERM RESULTS OF CARDIAC TRANSPLANTATION IN PATIENTS OLDER THAN SIXTY YEARS Advanced age has traditionally been a contraindication to cardiac transplantation. We have, however, offered cardiac transplantation
More informationPatient with Daily Headache NTERNATIONAL CLASSIFICATION HEADACHE DISORDERS. R. Allan Purdy, MD, FRCPC,FACP. Professor of Medicine (Neurology)
Patient with Daily Headache NTERNATIONAL CLASSIFICATION of R. Allan Purdy, MD, FRCPC,FACP HEADACHE DISORDERS Professor of Medicine (Neurology) 2nd edition (ICHD-II) Learning Issues Headaches in the elderly
More informationImmunosuppression Switch in Pediatric Heart Transplant Recipients: Cyclosporine to FK 506
JACC Vol. 25, No. 5 1183 April 1995:1183-8 Immunosuppression Switch in Pediatric Heart Transplant Recipients: Cyclosporine to FK 506 JEANINE M. SWENSON, MD, F. JAY FRICKER, MD, FACC, JOHN M. ARMITAGE,
More informationThe 1-year survival rate approaches 80% for patients
Lung Transplantation for Respiratory Failure Resulting From Systemic Disease Frank A. Pigula, MD, Bartley P. Griffith, MD, Marco A. Zenati, MD, James H. Dauber, MD, Samuel A. Yousem, MD, and Robert J.
More informationDemonstration of Uneven. the infusion on myocardial temperature was insufficient
Demonstration of Uneven in Patients with Coronary Lesions Rolf Ekroth, M.D., HAkan erggren, M.D., Goran Sudow, M.D., Josef Wojciechowski, M.D., o F. Zackrisson, M.D., and Goran William-Olsson, M.D. ASTRACT
More informationCardiovascular System Notes: Heart Disease & Disorders
Cardiovascular System Notes: Heart Disease & Disorders Interesting Heart Facts The Electrocardiograph (ECG) was invented in 1902 by Willem Einthoven Dutch Physiologist. This test is still used to evaluate
More informationAdvanced Heart Failure and Transplant Cardiology
Advanced Heart Failure and Transplant Cardiology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Loupy A, Lefaucheur C, Vernerey D, et al. Complement-binding
More informationCIRCULATORY SYSTEM TASK CARDS Worksheet
CIRCULATORY SYSTEM TASK CARDS Worksheet Name: Date: Instructions: Put the answers to each task card in the numbered boxes on the chart. 1 a) left semilunar valve / aortic valve b) blood would backflow
More informationIndex of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125
145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency
More informationReduced graft function (with or without dialysis) vs immediate graft function a comparison of long-term renal allograft survival
Nephrol Dial Transplant (2006) 21: 2270 2274 doi:10.1093/ndt/gfl103 Advance Access publication 22 May 2006 Original Article Reduced graft function (with or without dialysis) vs immediate graft function
More informationThe Mammalian Circulatory System
The Mammalian Heart The Mammalian Circulatory System Recall: What are the 3 cycles of the mammalian circulatory system? What are their functions? What are the three main vessel types in the mammalian circulatory
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationPost-Transplant Monitoring for the Development of Anti-Donor HLA Antibodies
Post-Transplant Monitoring for the Development of Anti-Donor HLA Antibodies Lorita M Rebellato, Ph.D., D (ABHI) Associate Professor Department of Pathology The Brody School of Medicine at ECU Scientific
More informationHemoglobin regeneration as influenced by diet and other factors*
G E O R G E H. WH I P P L E Hemoglobin regeneration as influenced by diet and other factors* Nobel Lecture, December 12, 1934 Experiments usually have a past history or a genealogical sequence, and it
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationP process or in association with progressive cardiac
Chronic Cardiac Rejection Masking as Constrictive Pericarditis Thomas J. Hinkamp, MD, Henry J. Sullivan, MD, Alvaro Montoya, MD, Soon Park, MD, Linda Bartlett, RN, and Roque Pifarre, MD Loyola University
More informationLeft Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients
Left Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients Armand A. Lefemine, M.D., Rajagopalan Govindarajan, M.D., K. Ramaswamy, M.D., Harrison
More informationCh.15 Cardiovascular System Pgs {15-12} {15-13}
Ch.15 Cardiovascular System Pgs {15-12} {15-13} E. Skeleton of the Heart 1. The skeleton of the heart is composed of rings of dense connective tissue and other masses of connective tissue in the interventricular
More informationCARDIOVASCULAR SURGERY
Volume 107, Number 4 April 1994 The Journal of THORACIC AND CARDIOVASCULAR SURGERY Cardiac and Pulmonary Transplantation Risk factors for graft failure associated with pulmonary hypertension after pediatric
More informationDevelopment of Cardiac Transplantation
Historical Perspectives Daniel J. DiBardino The History and Development of Cardiac Transplantation The history of heart surgery, spanning only 100 years to date, has seen some of the most daring and persistent
More informationThe blood returns from the body and enters right atrium using the vena cava. It passes through the tricuspid valve to the right ventricle.
The blood returns from the body and enters right atrium using the vena cava. It passes through the tricuspid valve to the right ventricle. From this camber, it passes through the pulmonary semilunar valve
More informationEchocardiography analysis in renal transplant recipients
Original Research Article Echocardiography analysis in renal transplant recipients S.A.K. Noor Mohamed 1*, Edwin Fernando 2, 1 Assistant Professor, 2 Professor Department of Nephrology, Govt. Stanley Medical
More informationDifferentiation of Ventricular Tachycardia from Junctional Tachycardia with Aberrant Conduction
Differentiation of Ventricular Tachycardia from Junctional Tachycardia with Aberrant Conduction The Use of Competitive Atrial Pacing By ROBERT M. EASLEY, JR., M.D., AND SIDNEY GOLDSTEIN, M.D. SUMMARY A
More informationEmerging Drug List EVEROLIMUS
Generic (Trade Name): Manufacturer: Everolimus (Certican ) Novartis Pharmaceuticals NO. 57 MAY 2004 Indication: Current Regulatory Status: Description: Current Treatment: Cost: Evidence: For use with cyclosporine
More informationBellwork Define: hemostasis anticoagulation hemophilia (Then write the underline portion of the two state standards in your notes).
Bellwork Define: hemostasis anticoagulation hemophilia (Then write the underline portion of the two state standards in your notes). A&P Standards 31) Identify the liquid and cellular components of blood
More informationPostoperative atrial fibrillation is not an innocuous arrhytmia in LAVD patients
Accepted Manuscript Postoperative atrial fibrillation is not an innocuous arrhytmia in LAVD patients Cipriano Abad, MD, PhD, FEBS(Hon, Gen Surg), EBCTS, Stefano Urso, MD, PhD, Bernardino Clavo, MD, PhD
More informationwith the Spiral Composite Vein Graft
Redacement of Superior Vena Cava with the Spiral Composite Vein Graft A Versatile Technique C. J. Chiu, M.D., J. Terzis, M.D., and M. L. MacRae, B.S. ABSTRACT A technique to construct a spiral vein graft
More informationCHAPTER 4 SECTION 24.2 HEART TRANSPLANTATION TRICARE POLICY MANUAL M, AUGUST 1, 2002 SURGERY. ISSUE DATE: December 11, 1986 AUTHORITY:
SURGERY CHAPTER 4 SECTION 24.2 ISSUE DATE: December 11, 1986 AUTHORITY: 32 CFR 199.4(e)(5) I. CPT 1 PROCEDURE CODES 33940-33945, 33975-33980 II. POLICY A. Benefits are allowed for heart transplantation.
More informationI topic liver transplantation (OLT) to avoid organ
ORIGINAL ARTICLES Long-Term Immunosuppression Without Corticosteroids After Orthotopic Liver Transplantation: A Positive Therapeutic Aim Gerald M. Fraser, * Kons tantinos Grammous tianos, Jayendravandan
More informationPulmonary Valve Replacement
Pulmonary Valve Replacement with Fascia Lata J. C. R. Lincoln, F.R.C.S., M. Geens, M.D., M. Schottenfeld, M.D., and D. N. Ross, F.R.C.S. ABSTRACT The purpose of this paper is to describe a technique of
More information